Screener
Matinas BioPharma MTNB Q1 2025 Annual earnings
Reported April 15, 2025 · Before market open
EPS-$1.68Miss by $0.90
EPS estimate-$0.78
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$25.0K
EPS estimate-$1.32
Versus estimates
Diluted EPS
Q2 2026-$0.21Beat by $1.11Q1 2026-$0.30Beat by $1.02Q4 2025-$0.24Beat by $1.08Q3 2025-$0.40Q2 2025-$1.03
Q1 2025-$1.68Miss by $0.90
FAQ
- When did Matinas BioPharma report Q1 2025 earnings?
- Matinas BioPharma (MTNB) reported Q1 2025 earnings on April 15, 2025 before market open.
- What were Matinas BioPharma's Q1 2025 revenue and EPS?
- Matinas BioPharma reported eps of $-1.68 for Q1 2025.
- Did Matinas BioPharma beat estimates in Q1 2025?
- EPS missed the consensus estimate of $-0.78 by $0.90.
- How did Matinas BioPharma's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 12.0% from $-1.50.
- Where can I find Matinas BioPharma's Q1 2025 SEC filings?
- You can read the 10-K periodic report (0001641172-25-004882) directly on SEC EDGAR. The filing index links above go to sec.gov.
